the UK marketplace for company sales

Aesthetics wholesale and pharmacy

£5m to £10m
Health & care, Medical, Miscellaneous, Retail & wholesale
North West England, UK Wide
08 February 2024

Business description

Offered for sale are the two powerhouse wholesale and pharma businesses behind a growing aesthetics group established several years ago. Together, the businesses generated over £7.7 million in sales and £473,191 in adjusted EBITDA in 2023, demonstrating a strong and growing market presence.

The wholesale arm specialises in the distribution of non-prescription medical devices for both medics and non-medic aesthetics professionals, including but not limited to dermal fillers, fat dissolvers, PDO threads, skin boosters, etc. It has quickly grown to become one of the industry’s largest retailers, averaging over 100 orders daily.

In 2022, the group strengthened its offering by becoming a trusted distribution partner for leading aesthetics brands like Monalisa dermal filler, Singderm dermal filler, Extra by KLMEDI dermal filler, and EpLine PDO thread, providing customers with access to a wide range of high-quality products.

The pharma arm is a fully-regulated and GPhC- and MHRA-compliant pharmacy, specialising in non-NHS private prescriptions of specialist aesthetics treatments to medical and non-medical professional. It is currently undergoing approval for an international Wholesale Distribution Authorisation (WDA) licence to allow wholesale deals, which promises to significantly boost revenue. 

The company benefits from a qualified Superintendant Pharmacist who oversees the pharmacy’s day-to-day operations, while ensuring GPhC and MHRA compliance.   

Together, the pharmacy and wholesale facility fulfil 1000 orders per week.  


  • Direct contracts with leading suppliers, resulting in a cost-effective supply chain and strong profit margins, exceeding 20% per item.
  • Trusted distribution partner for brands such as Monalisa dermal filler, Singderm dermal filler, Extra by KLMEDI dermal filler, and EpLine PDO thread.
  • A 5,000-strong returning client base, with approximately 1000 orders fulfilled weekly.
  • In-place business Superintendant Pharmacist, ensuring GPhC and MHRA compliance.
  • Excellent national and international reach facilitated by a strong digital presence and the company’s own e-commerce sales platforms.
  • Formidable financial profile with significant year-over-year revenue growth – from £3.4m in 2022 to £7.7m in 2023.


Turnover (£'000) Adjusted EBITDA (£'000)
2021 (Actual) 4,431,700 369,447
2022 (Actual) 3,411,960 291,924
2023 (Actual) 7,715,900 473,191


Pending international WDA license for the pharma arm promises significant revenue growth, while P-licensed products and a beauty product line offer opportunities for portfolio diversification.

Prospective purchasers

  • 100% share capital.
  •  Interested parties to sign an NDA.         
  • Leasehold premises available.

Reason for sale

The shareholders wish to spend more time with family.

Contacting the person who posted this opportunity

All opportunities on this website have been posted by advisers, or occasionally by company owners. Deal Opportunities Limited is not acting on any of these opportunities.

All the information available to us for this opportunity is shown above. We do not have any additional information.

Please contact the person responsible for this opportunity in order to request further information, or to express an interest in it.

You are not currently logged in to the site. If you are a regular user, please log in before requesting contact details.

Register Log in now Get their contact details without logging in

Log in

Forgot your password? | Don't have an account? Register here

Please submit your contact details

Once submitted, an automated email will be sent to you giving you the full contact details of the person responsible for this opportunity. This is entirely free of charge.

Your contact details:

Businesses for sale